Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gelatine versus compound sodium lactate in critically ill ICU patients
ACTRN12617001461381Phase 2Completed
- Sponsor
- Royal Perth Hospital Medical Research Foundation
- Start
- Nov 2018
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in critical illness and Cardiovascular collapse comparing 4% succinylated gelatine with Compound sodium lactate (2 arms). Primary endpoints: Change in urine NGAL concentration over time after first dose of study fluid and Change in urine cystatin C concentration over time after first dose of study fluid. Started Nov 2018; status: completed.
02
Drugs
succinylated gelatinlactated ringer's solution
03
Conditions
critical illnessCardiovascular collapse
Beyond the preview
Go deeper on ACTRN12617001461381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12617001461381.